[Writer's cramp].
Sangla
S
S
Fédération de neurologie, Hôpital de la Salpétrière, Paris.
Tranchant
C
C
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D002998:Clonazepam / Q000627:therapeutic use; D003131:Combined Modality Therapy; D012090:Cumulative Trauma Disorders / Q000175:diagnosis; D003937:Diagnosis, Differential; D018450:Disease Progression; D020821:Dystonic Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology / Q000534:rehabilitation; D020022:Genetic Predisposition to Disease; D006225:Hand / Q000503:physiopathology; D006801:Humans; D009422:Nervous System Diseases / Q000175:diagnosis; D009460:Neurologic Examination; D026741:Physical Therapy Modalities; D011433:Propranolol / Q000627:therapeutic use
D002998:Clonazepam; D011433:Propranolol; D019274:Botulinum Toxins, Type A